Healthcare Services

Impact Of Rising Alcohol Consumption On Market Growth Is Supporting Development Across The Liver Disease Diagnostics Market

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Size Of The Liver Disease Diagnostics Market Progress Through 2030?

The liver disease diagnostics market has experienced robust growth in recent years. It is projected to expand from $38.95 billion in 2025 to $41.84 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. This historic growth is largely attributable to factors such as the increasing prevalence of hepatitis infections, rising alcohol consumption patterns, early reliance on blood-based liver tests, a growing incidence of liver cirrhosis, and the expansion of hospital diagnostic infrastructure.

The liver disease diagnostics market is projected to achieve significant expansion over the next few years, with its valuation expected to climb to $55.17 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.2%. This anticipated growth is driven by several factors, including the increasing incidence of NAFLD and NASH, a heightened awareness regarding preventive liver care, the growing adoption of advanced imaging techniques, the proliferation of population health screening programs, and greater healthcare spending on diagnostics. Prominent trends throughout this period include an escalating demand for early detection of liver diseases, a rise in the application of non-invasive diagnostic methods, more extensive screening for fatty liver and fibrosis, an expansion of routine liver function testing, and an increased clinical emphasis on monitoring disease progression.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20862&type=smp

Which Growth Drivers Are Expected To Support The Liver Disease Diagnostics Market Forward?

The growing intake of alcohol is projected to fuel the expansion of the liver disease diagnostics market moving forward. This rise in alcohol consumption is attributed to factors such as evolving social norms, greater economic accessibility, widespread availability, and increasing stress or mental health challenges. Liver disease diagnostics are essential for monitoring the effects of alcohol intake on liver health, assisting in the early detection of liver damage signs like fatty liver, hepatitis, or cirrhosis. For instance, in December 2024, the Bureau of Labor Statistics, a US-based government agency, indicated that in 2023, U.S. households spent an average of $294 on alcoholic beverages consumed at home and $343 on those consumed outside the home. Therefore, the increase in alcohol consumption is a primary driver for the growth of the liver disease diagnostics market.

What Are The Major Segment Categories Within The Liver Disease Diagnostics Market?

The liver disease diagnostics market covered in this report is segmented –

1) By Diagnosis Technique: Laboratory Tests, Imaging, Biopsy, Other Diagnosis Techniques

2) By Disease: Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Fibrosis, Cirrhosis, Hepatocellular Carcinoma, Other Diseases

3) By End Users: Hospitals, Laboratories, Other End Users

Subsegments:

1) By Laboratory Tests: Blood Tests (Liver Function Tests, Hepatitis Panel), Enzyme Tests (ALT, AST, ALP), Serological Tests

2) By Imaging: Ultrasound Imaging, CT Scans, MRI, Elastography (FibroScan)

3) By Biopsy: Liver Biopsy (Needle Biopsy), Fine Needle Aspiration Biopsy, Laparoscopic Biopsy

4) By Other Diagnosis Techniques: Biomarker Testing, Fibrosis Scoring Systems

What Trends Are Influencing The Future Of The Liver Disease Diagnostics Market?

Leading companies in the liver disease diagnostics market are concentrating on developing innovative solutions, such as non-invasive methods for liver assessment, to create more precise and effective diagnostic approaches. A non-invasive tool for liver assessment refers to diagnostic techniques that evaluate liver conditions using methods like elastography or blood tests, thereby eliminating the need for invasive procedures such as biopsies. For example, in September 2024, City Imaging & Clinical, an India-based diagnostic center, introduced FibroScan, a non-invasive diagnostic tool for liver assessment, intended for the early detection of liver ailments including non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). This advanced technology enables rapid and accurate measurements of liver stiffness and fat content without requiring invasive interventions like biopsies. The procedure is quick, typically lasting 5 to 15 minutes, and involves placing a probe on the skin over the liver. The probe then emits sound waves, which measure liver tissue stiffness, aiding in the assessment of fibrosis or scarring.

Which Organizations Are Involved In The Liver Disease Diagnostics Market?

Major companies operating in the liver disease diagnostics market are F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Fujifilm Holdings Corporation, Boston Scientific Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, bioMérieux SA, Echosens SA, Hologic Inc., Canon Medical Systems Corporation, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Samsung Medison Co. Ltd., Bruker Corporation, Sysmex Corporation, DiaSorin S.p.A., Perspectum Diagnostics Ltd., Owlstone Medical Ltd., HEPQuant LLC, Aiforia Technologies Plc

Access The Complete Liver Disease Diagnostics Market Report:

https://www.thebusinessresearchcompany.com/report/liver-disease-diagnostics-global-market-report

Which Region Commands The Largest Share Of The Liver Disease Diagnostics Market?

North America was the largest region in the liver disease diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver disease diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Liver Disease Diagnostics Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20862&type=smp

Browse Through More Reports Similar to the Global Liver Disease Diagnostics Market 2026, By The Business Research Company

Hepatitis Diagnostic Tests Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Liver Diseases Therapeutics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Clinical Diagnostics Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795